The document discusses challenges in conducting clinical research on rare tumors due to small patient populations. Conventional statistical methods require large sample sizes to prove efficacy, but rare tumors may only have a few hundred worldwide cases per year. This makes it difficult to demonstrate efficacy of new treatments according to standard evidence-based medicine criteria. International cooperation is needed but faces challenges related to funding, bureaucracy and standardization across countries.